An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.

Cells change their ribosomes when they receive a danger signal from the immune system, the new study showed. “They change the balance toward a type of ribosome that has a flexible arm sticking out, ...

The genome is "stirred" by transcription-driven motions of single genes, furthering our understanding of the human genome in ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

In this GEN webinar, Mark Stockdale will discuss how the application of synthetic biology and artificial intelligence can be ...

Two public companies focused on RNA editing therapies, Korro Bio and ProQR, enjoyed impressive stock surges powered by their best-ever one day gains; their share prices lifted by Wave Life Sciences ...

Seaport Therapeutics said today it has closed on an oversubscribed $225 million Series B financing, with the proceeds set to ...

Researchers suggest research findings might be applicable to other age-related diseases where endothelial dysfunction plays a ...

Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

Modifying a protein that controls cell growth can reactivate dormant neural stem cells in fruit flies which could help ...

The awards celebrate the discovery of a new role for CD4 T cells in the cancer immune response and insights into autoimmune ...